SELLAS Life Sciences Group, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SLS, updated each market day.
SLS AI Sentiment
AI sees no strong directional signal for SELLAS Life Sciences Group, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About SELLAS Life Sciences Group, Inc. Common Stock
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Sector
Exchange
Market Cap
$906,891,998
Cap Tier
Employees
13
Headquarters
NEW YORK, NY
Listed Since
March 12, 2008
SLS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SLS Volatility
SELLAS Life Sciences Group, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
